DBP-117

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameDBP-117
Drug Alias Namemigraine therapy (BioProgress)triptan migraine therapy (Meldex)DBP-117
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMigraine Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMeldex International
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMeldex International
Active IndicationsN/A
Inactive IndicationsMigraine Disorders

Other Information

ATC CodeN/A
Related LinksN/A